Article citationsMore >>

Hanukoglu A, “Type 1 pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects,” J Clin Endocrinol Metab, 70:936-944. 1991.

has been cited by the following article:

Article

First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism

1Department of Pediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan


American Journal of Medical Case Reports. 2015, Vol. 3 No. 3, 91-92
DOI: 10.12691/ajmcr-3-3-11
Copyright © 2015 Science and Education Publishing

Cite this paper:
Yuichiro Imai, Junji Takaya, Kazunari Kaneko. First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism. American Journal of Medical Case Reports. 2015; 3(3):91-92. doi: 10.12691/ajmcr-3-3-11.

Correspondence to: Junji  Takaya, Department of Pediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan. Email: takaya@kawati.or.jp

Abstract

In the present case with primary pseudohypoaldosteronism, severe hypekalemia was treated with salbutamol inhalation in acute phase. Transcellular hypokalemic effect of salbutamol is related to the activation of Na-K pump on the cell membrane. Although use of salbutamol inhalation in hyperkalemia was previously described, it has not been widely used. The administration of salbutamol by inhalation is a simple, safe and reasonably effective method for treatment of hyperkalemia even in children.

Keywords